210 related articles for article (PubMed ID: 24799155)
1. The "no reflow" phenomenon following acute myocardial infarction: mechanisms and treatment options.
Kaul S
J Cardiol; 2014 Aug; 64(2):77-85. PubMed ID: 24799155
[TBL] [Abstract][Full Text] [Related]
2. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
Wu X; Mintz GS; Xu K; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW; Maehara A
JACC Cardiovasc Interv; 2011 May; 4(5):495-502. PubMed ID: 21596321
[TBL] [Abstract][Full Text] [Related]
3. Myocardial 'no-reflow'--diagnosis, pathophysiology and treatment.
Wong DT; Puri R; Richardson JD; Worthley MI; Worthley SG
Int J Cardiol; 2013 Sep; 167(5):1798-806. PubMed ID: 23357047
[TBL] [Abstract][Full Text] [Related]
4. Predicting the no-reflow phenomenon following successful percutaneous coronary intervention.
Galiuto L; Paraggio L; Liuzzo G; de Caterina AR; Crea F
Biomark Med; 2010 Jun; 4(3):403-20. PubMed ID: 20550474
[TBL] [Abstract][Full Text] [Related]
5. Reperfusion arrhythmias: are they only a marker of epicardial reperfusion or continuing myocardial ischemia after acute myocardial infarction?
Heper G; Korkmaz ME; Kilic A
Angiology; 2007 Dec-2008 Jan; 58(6):663-70. PubMed ID: 17989422
[TBL] [Abstract][Full Text] [Related]
6. Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli.
Sakuma T; Leong-Poi H; Fisher NG; Goodman NC; Kaul S
J Am Soc Echocardiogr; 2003 Jan; 16(1):15-21. PubMed ID: 12514630
[TBL] [Abstract][Full Text] [Related]
7. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
[TBL] [Abstract][Full Text] [Related]
8. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ
JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671
[TBL] [Abstract][Full Text] [Related]
9. Management of the no-reflow phenomenon.
Butler MJ; Chan W; Taylor AJ; Dart AM; Duffy SJ
Pharmacol Ther; 2011 Oct; 132(1):72-85. PubMed ID: 21664376
[TBL] [Abstract][Full Text] [Related]
10. Myocardial 'no-reflow' prevention.
Magro M; Springeling T; van Geuns RJ; Zijlstra F
Curr Vasc Pharmacol; 2013 Mar; 11(2):263-77. PubMed ID: 23506503
[TBL] [Abstract][Full Text] [Related]
11. Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction.
Zhao JL; Fan CM; Yang YJ; You SJ; Gao X; Zhou Q; Pei WD
Cardiovasc Ther; 2013 Feb; 31(1):60-4. PubMed ID: 21884027
[TBL] [Abstract][Full Text] [Related]
12. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
[TBL] [Abstract][Full Text] [Related]
13. Primary coronary angioplasty in acute myocardial infarction: clinical correlates of the 'no reflow' phenomenon.
Marzilli M; Gliozheni E; Marraccini P; Fedele S
Int J Cardiol; 1998 May; 65 Suppl 1():S23-8. PubMed ID: 9706823
[TBL] [Abstract][Full Text] [Related]
14. Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Akpek M; Sahin O; Sarli B; Baktir AO; Saglam H; Urkmez S; Ergin A; Oguzhan A; Arinc H; Kaya MG
Angiology; 2015 Jul; 66(6):560-7. PubMed ID: 25092681
[TBL] [Abstract][Full Text] [Related]
15. Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling.
Niccoli G; Cosentino N; Lombardo A; Sgueglia GA; Spaziani C; Fracassi F; Cataneo L; Minelli S; Burzotta F; Maria Leone A; Porto I; Trani C; Crea F
Coron Artery Dis; 2011 Nov; 22(7):507-14. PubMed ID: 21857508
[TBL] [Abstract][Full Text] [Related]
16. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model.
Dai W; Hale S; Kloner RA
Int J Cardiol; 2017 Jun; 236():400-404. PubMed ID: 28108128
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction.
Iwakura K; Ito H; Kawano S; Shintani Y; Yamamoto K; Kato A; Ikushima M; Tanaka K; Kitakaze M; Hori M; Higashino Y; Fujii K
J Am Coll Cardiol; 2001 Aug; 38(2):472-7. PubMed ID: 11499740
[TBL] [Abstract][Full Text] [Related]
18. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction.
Ito H; Maruyama A; Iwakura K; Takiuchi S; Masuyama T; Hori M; Higashino Y; Fujii K; Minamino T
Circulation; 1996 Jan; 93(2):223-8. PubMed ID: 8548892
[TBL] [Abstract][Full Text] [Related]
20. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
